Dosaka-Akita H - Search Results

1

Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.

Kanazawa K, Yokouchi H, Wang X, Ishida T, Fujita Y, Fujiuchi S, Harada T, Harada M, Takamura K, Oizumi S, Kinoshita I, Katsuura Y, Honjo O, Kojima T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M; Hokkaido Lung Cancer Clinical Study Group. Kanazawa K, et al. Cancer Chemother Pharmacol. 2014 Dec;74(6):1149-57. doi: 10.1007/s00280-014-2589-3. Epub 2014 Oct 8. Cancer Chemother Pharmacol. 2014. PMID: 25294632 Clinical Trial.

2

Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer.

Harada M, Dosaka-Akita H, Miyamoto H, Kuzumaki N, Kawakami Y. Harada M, et al. Cancer. 1992 Jan 1;69(1):72-7. doi: 10.1002/1097-0142(19920101)69:1<72::aid-cncr2820690114>3.0.co;2-a. Cancer. 1992. PMID: 1309311

3

[Clinical significance of oncogene product expression in human lung cancer].

Dosaka-Akita H, Harada M, Miyamoto H, Kawakami Y. Dosaka-Akita H, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Aug;30(8):1441-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1331597 Japanese.

4

Simultaneous use of the PCR-SSCP method and immunohistochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer.

Fujino M, Dosaka-Akita H, Kato M, Kinoshita I, Akie K, Kawakami Y. Fujino M, et al. Am J Clin Pathol. 1995 Sep;104(3):319-24. doi: 10.1093/ajcp/104.3.319. Am J Clin Pathol. 1995. PMID: 7677121

5

Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung.

Kinoshita I, Dosaka-Akita H, Shindoh M, Fujino M, Akie K, Kato M, Fujinaga K, Kawakami Y. Kinoshita I, et al. Br J Cancer. 1995 Feb;71(2):344-9. doi: 10.1038/bjc.1995.69. Br J Cancer. 1995. PMID: 7841051 Free PMC article.

6

Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.

Dosaka-Akita H, Akie K, Hiroumi H, Kinoshita I, Kawakami Y, Murakami A. Dosaka-Akita H, et al. Cancer Res. 1995 Apr 1;55(7):1559-64. Cancer Res. 1995. PMID: 7882365

7

Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history.

Dosaka-Akita H, Shindoh M, Fujino M, Kinoshita I, Akie K, Katoh M, Kawakami Y. Dosaka-Akita H, et al. Am J Clin Pathol. 1994 Nov;102(5):660-4. doi: 10.1093/ajcp/102.5.660. Am J Clin Pathol. 1994. PMID: 7942633

8

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.

Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y. Fujino M, et al. Cancer. 1995 Dec 15;76(12):2457-63. doi: 10.1002/1097-0142(19951215)76:12<2457::aid-cncr2820761209>3.0.co;2-x. Cancer. 1995. PMID: 8625071

9

"Web-like obstruction"--a sign of regional complete remission after concurrent chemoradiotherapy in small cell lung cancer.

Hanada T, Ogura S, Isobe H, Dosaka-Akita H, Yamazaki K, Watanabe N, Kawakami Y. Hanada T, et al. Intern Med. 1996 Sep;35(9):732-5. doi: 10.2169/internalmedicine.35.732. Intern Med. 1996. PMID: 8915702 Free article.

10

Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.

Kinoshita I, Dosaka-Akita H, Mishina T, Akie K, Nishi M, Hiroumi H, Hommura F, Kawakami Y. Kinoshita I, et al. Cancer Res. 1996 Dec 15;56(24):5557-62. Cancer Res. 1996. PMID: 8971152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page